Marinus Pharmaceuticals Investor Relations Material
Latest events
Investor & Analyst 2024
Marinus Pharmaceuticals
Investor Presentation
12 Nov, 2024
Q3 2024
12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marinus Pharmaceuticals Inc
Access all reports
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy with a focus on rare and orphan seizures, as well as neuropsychiatric disorders in the United States.
Key slides for Marinus Pharmaceuticals Inc
Investor & Analyst 2024
Marinus Pharmaceuticals Inc
Investor & Analyst 2024
Marinus Pharmaceuticals Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MRNS
Country
🇺🇸 United States